Kewaunee Scientific Corporation KEQU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.73% | -7.45% | 3.32% | 46.75% | 46.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.73% | -7.45% | 3.32% | 46.75% | 46.93% |
| Cost of Revenue | -6.96% | -5.56% | 4.23% | 48.99% | 39.74% |
| Gross Profit | -6.17% | -11.62% | 0.90% | 41.34% | 67.60% |
| SG&A Expenses | 2.24% | 3.16% | -1.03% | 64.04% | 62.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.72% | -3.59% | 2.93% | 52.29% | 44.69% |
| Operating Income | -34.35% | -38.64% | 14.76% | -7.37% | 86.80% |
| Income Before Tax | -34.69% | -33.47% | 25.80% | -12.16% | 61.32% |
| Income Tax Expenses | -5.78% | -51.68% | 588.89% | -0.11% | 296.35% |
| Earnings from Continuing Operations | -41.66% | -25.37% | -22.20% | -15.82% | 41.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -107.58% | -213.40% | -1,224.14% | -1,228.57% | -46.67% |
| Net Income | -44.84% | -30.14% | -48.89% | -18.72% | 41.04% |
| EBIT | -34.35% | -38.64% | 14.76% | -7.37% | 86.80% |
| EBITDA | -25.32% | -30.88% | 9.60% | 8.53% | 87.58% |
| EPS Basic | -45.40% | -30.44% | -48.77% | -18.55% | 40.95% |
| Normalized Basic EPS | -39.25% | -39.21% | -19.30% | -15.52% | 61.65% |
| EPS Diluted | -44.23% | -30.73% | -48.89% | -18.81% | 40.54% |
| Normalized Diluted EPS | -37.75% | -39.23% | -19.15% | -16.16% | 61.99% |
| Average Basic Shares Outstanding | 1.02% | 0.42% | -0.21% | -0.21% | 0.07% |
| Average Diluted Shares Outstanding | -1.42% | 0.47% | -0.40% | 0.54% | -0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |